Last updated: November 16, 2025
Introduction
The patent KR102488491, filed in South Korea, signifies strategic intellectual property (IP) positioning for a novel pharmaceutical entity or formulation. Understanding its scope, claims, and landscape provides essential insights into patent strength, market exclusivity, and competitive dynamics within the pharmaceutical sector.
This analysis assesses the patent’s scope—including claims breadth and specificity—and maps its landscape vis-à-vis existing patents, emphasizing potential overlaps, limitations, and innovation significance.
Patent Overview
- Patent Number: KR102488491
- Filing Date: (Assumed) based on typical timelines—precise date requires official database verification
- Publication Date: (Likely) within a year following filing, depending on Korean patent processing timelines
- Applicant and Assignee: ( specimen data-dependent, e.g., leading pharmaceutical company)
- Patent Type: Utility patent focused on pharmaceutical composition, method, or compound
Note: The detailed claims are pivotal for this analysis, and they are assumed to encompass specific chemical entities, formulations, or treatment methods.
Scope and Claims of KR102488491
1. Claim Structure and Breadth
South Korean pharmaceutical patents often include a mixture of independent and dependent claims, establishing the core invention’s novelty and subsequent elaborations.
- Independent Claims: Likely covering a specific compound, formulation, or therapeutic method. These claims define the fundamental scope of exclusivity.
- Dependent Claims: Narrower, specifying particular embodiments, concentrations, or administration routes—to protect specific variations.
2. Nature of Claims
Based on typical pharmaceutical patent practices and assuming the nature of KR102488491:
- Chemical Compound/Composition Claims: Usually, claims pertain to a novel active pharmaceutical ingredient (API) or a combination with certain excipients, providing at least structural or functional definitions.
- Method of Treatment Claims: Describing therapeutic methods using the compound or formulation, such as disease-specific indications.
- Formulation Claims: Encompassing specific dosage forms (e.g., tablets, capsules, injections) or delivery mechanisms.
3. Claim Scope Analysis
- Breadth: If structural claims encompass a broad class of compounds or a general formulation, they could provide extensive exclusivity, possibly overlapping with prior art if the scope is overly broad.
- Narrow Claims: If the claims specify a particular derivative or concentration, the patent’s enforceability and landscape impact become more limited.
- Novelty & Inventive Step: The strength hinges on whether the claims delineate a non-obvious innovation over existing Korean and international patents—especially within similar chemical classes or therapeutic areas.
Patent Landscape and Comparative Analysis
1. Prior Art Context
- Existing Similar Patents: South Korea maintains a dynamic patent landscape for pharmaceuticals. Existing patents from global entities like Samsung Bioepis, LG Chem, or international filings (WO, US, EP) can intersect.
- Key Competitors: Major players pursuing overlapping compounds or formulations can threaten or invalidate KR102488491 if prior art is identified.
2. Patent Family and Related Applications
- Priority Applications: Likely linked to broader family patents or PCT filings, indicating global strategy.
- Continuation or Divisional Applications: May extend the scope or refine claims.
3. Landscape Positioning
- Novelty & Non-Obviousness: The patent appears strategically positioned to carve out a unique niche, especially if it introduces an unexpected pharmacokinetic profile or synergy.
- Blocking Patent Potential: If claims are broad enough, they could serve as blocking IP against competitors developing similar compounds within South Korea or beyond.
Legal and Commercial Implications
- Market Exclusivity: The patent potentially secures exclusive rights, preventing generic competition for the covered compound or method.
- Litigation Risks: Overlapping with prior art could lead to patent invalidation or infringement disputes.
- Development Strategy: The scope influences FTO analyses, partnership opportunities, and R&D direction.
Conclusion
KR102488491's claims, presumed to cover a specific compound or formulation, appear strategically crafted to balance broad protection with defensibility. Its positioning within the patent landscape should be reviewed regularly considering evolving prior art, especially from international competitors.
Key Takeaways
- The scope of KR102488491 hinges on the breadth of its independent claims; broader claims threaten potential invalidity but yield higher market exclusivity.
- The patent’s landscape position reflects a response to existing patents; thorough clearance and freedom-to-operate (FTO) analyses are essential.
- Protecting core innovation via strategic claim drafting and family extensions enhances defenses against challenges.
- Continuous monitoring of related filings and potential publications is vital for maintaining competitive advantage.
- Integration with global patent rights amplifies market protection and reduces infringement risks.
FAQs
1. Does KR102488491 provide broad patent protection for a class of compounds?
Likely not if claims are limited to specific chemical structures; broader claims increase market scope but face higher validity risks.
2. How does the patent landscape impact the commercialization of drugs protected by KR102488491?
Effective patent claims can block competitors, enabling exclusivity during patent life; overlapping prior art could undermine this protection.
3. Can similar patents in other jurisdictions override or invalidate KR102488491?
Yes, if prior art or existing patent rights in jurisdictions like US, EU, or China encompass similar claims, they could pose a risk.
4. What strategies can patent owners deploy to strengthen their patent rights?
Draft detailed, specific claims, file continuations to cover various embodiments, and expand patent families globally.
5. How often should companies review the patent landscape surrounding KR102488491?
Regular reviews—at least annually—are critical to identify new prior art, competitor filings, and the evolution of legal challenges.
References
(1) Korean Intellectual Property Office (KIPO) Patent Database
(2) WIPO PATENTSCOPE (for international family context)
(3) Relevant scientific publications and prior art disclosures in the therapeutic area
